- Recommendation ID
- IPG616/1
- Question
Further research on the efficacy and safety of intranasal phototherapy for allergic rhinitis should include: details of patient selection including medication use; underlying medical conditions; the intensity, duration and wavelength of light used; patient-reported outcomes; comparison with existing treatments; and the effects of repeated long-term use. NICE may update the guidance if further evidence is published.
- Any explanatory notes
(if applicable) Current evidence on the efficacy and safety of intranasal phototherapy for allergic rhinitis is limited in quantity and quality. Therefore, this procedure should only be used in the context of research.
Source guidance details
- Comes from guidance
- Intranasal phototherapy for allergic rhinitis
- Number
- IPG616
- Date issued
- June 2018
Other details
| Is this a recommendation for the use of a technology only in the context of research? | Yes |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/06/2018 |